Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

SAHVAI‐3D and 4D: Automated AI Volumetric Measurement of Subarachnoid Hemorrhage on Noncontrast Head CT
Wirtz, Melina, Salman, Saif , Wei, Yujia , Patel, Vishal , Sharma, Rohan , Gupta, Vikash , Gu, Qiangqiang , Dherin, Benoît , Reddy, Sanjana , Patel, Vishal N, Freeman, William D , Tawk, Rabih G. , Erickson, Bradley J. , Freeman, William D.

Stroke: Vascular and Interventional Neurology | April 12, 2025 | Volume: 5 | Issue: 3 | Pages: No page available

10.1161/svin.124.001620 | PMID 41573412 Get It

Background We automated subarachnoid hemorrhage volume (SAHV) calculation with artificial intelligence (SAHVAI) and created 3‐dimensional volumetric images (SAHVAI‐3D) using noncontrast head computed tomography data for patients with aneurysmal SAH. We also defined 4‐dimensional SAHVAI (SAHVAI‐4D), representing SAHV over time. We aimed to compare automated SAHVAI values and computational times to manual SAHV measurement methods, explore the potential of imaging biomarkers to identify at‐risk brain regions for delayed cerebral ischemia and explore potential insights in future neurotherapeutic interventions for patient recovery after SAH. Methods A training set of 10 consecutive patients with aneurysmal SAH was used to manually compute SAHV, SAHVAI‐3D, and SAHVAI‐4D, including 92 noncontrast computed tomography scans (182 slices each). The SAHVAI deep learning algorithm generated automated SAHV values in cubic centimeters. A 3‐dimensional SAH brain map was created for each patient for the SAHVAI and manual evaluations. Blood volumetric outputs were analyzed and compared to neurologic outcomes at discharge, including delayed cerebral ischemia events, symptomatic vasospasm, and areas with the thickest SAH blood concentration. Results SAHVAI quantified SAHV in a mean of 6.7 seconds per scan, significantly faster than the manual method, which took >60 minutes per scan (Fisher exact test, P <0.001). SAHVAI demonstrated an accuracy of 99.8%, Dice score of 0.701, false‐positive rate of 0.0005, and negative predictive value of 0.999. The mean absolute error between SAHVAI and manual methods was 5.67 mL. SAHVAI‐3D brain map and total SAHV at admission were inversely associated with Glasgow Coma Scale (R 2 = 0.23, P = 0.017) and directly associated with length of hospital stay (R 2 = 0.175, P = 0.004), especially in regions with dense blood concentration. Conclusion SAHVAI‐3D and SAHVAI‐4D brain mapping techniques represent innovative imaging biomarkers for SAH. These advancements enable rapid evaluation and targeted interventions, potentially improving patient care in SAH management.
An interactive care plan plus remote blood pressure monitoring in a rural primary care clinic: a pilot study
DeJesus, Ramona S. , Njeru, Jane W. , Beahm, Mark R., Gullerud, Rachel E., Grimm, Jessica A. , Copeland, Barbara J., Lunde, Julianne J. , Croghan, Ivana T.

Blood Pressure | April 12, 2025 | Volume: 34 | Issue: 1 | Pages: No page available

10.1080/08037051.2025.2490589 | PMID 40219656 Get It

Bilateral External Ear Canal Duplication: A Case Report
Ebbert, Landon E. , Crockett, David J. , Page, Nathan , Ebbert, Joshua , Amoo-Quaye, Grace, Hanson, Nana Andoh Mensah, Appiah–Thompson, Peter , Crockett, David, Page, Nathan C , Crockett, David

Ear, Nose & Throat Journal | April 12, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/01455613251333233 | PMID 40219830 Get It

Herein described is an eight-year-old female patient presenting with bilateral external ear canal duplication and a history of recurrent postauricular abscesses, otorrhea, and moderate left-sided conductive hearing loss. Previous incision and drainage of the postauricular abscesses yielded little long-term success. Medical history was otherwise unremarkable. Physical examination revealed a cystic mass in the right ear and postauricular fibrosis, likely a result of previous surgical interventions. An audiogram revealed asymmetric hearing function, with mild-to-moderate conductive hearing loss in the left ear contrasting normal hearing in the right ear, while tympanometry confirmed an intact right tympanic membrane but was precluded on the left due to purulent otorrhea. A head CT scan revealed postauricular soft tissue swelling and well-pneumatized mastoid air cells. Both ears were explored intraoperatively via postauricular incisions. Surgical excision included removal of a cyst, cartilaginous remnants, and fibrotic tissue. The patient was followed up to assess for postsurgical complications. The surgical site healed uneventfully; no new symptoms or recurrences of past symptoms of otorrhea, cyst formation, or abscesses had developed within the twelve weeks post-surgery. Although external ear canal duplications are rare, it is imperative that early, accurate diagnoses be made to ensure optimal patient outcomes.
The terrible triad of the shoulder: injury characteristics and outcomes of axillary nerve reconstruction
Wilson, Charlie D. , Welling, Benjamin D, Spinner, Robert J. , Shin, Alexander Y. , Shin, Alexander Y , Bishop, Allen T.

Journal of Hand Surgery (European Volume) | April 12, 2025 | Volume: 50 | Issue: 9 | Pages: 1185-1193

10.1177/17531934251333250 | PMID 40219809 Get It

We aimed to describe outcomes, including shoulder motion, deltoid strength and Disabilities of Arm, Shoulder and Hand scores, in 19 patients with terrible triad shoulder injuries (anterior shoulder dislocation, rotator cuff tear or greater tuberosity fracture, and axillary nerve injury) who required axillary nerve reconstruction. The type of nerve surgery (grafting vs. nerve transfer), demographic factors and injury characteristics were not significantly associated with outcomes. The mean postoperative abduction and Disabilities of Arm, Shoulder and Hand score were 95° and 28, respectively. Patients with rotator cuff tears had a higher Disabilities of Arm, Shoulder and Hand score (more disability) than those with isolated greater tuberosity fractures. We conclude that spontaneous recovery of the axillary nerve may not occur in patients with a terrible triad injury. Functional outcomes after axillary nerve repair are poor with respect to motion, strength and patient-reported outcomes compared with reported results for axillary nerve reconstruction in the absence of rotator cuff injury. Level of evidence: IV
Safety and Efficacy of Genicular Artery Embolization for Knee Joint Osteoarthritis Associated Pain: A Systematic Review
Ashraf, Nader , Tahir, Muhammad Junaid , Arabi, Tarek Ziad , Shaar, Bader Abou , Osman, Nadine , Mashkoor, Yusra , Ouban, Abderrahman , Abou Shaar, Bader , Asghar, Muhammad Sohaib , Arabi, Tarek , Fawzy, Nader A , Sabbah, Belal Nedal , Khan, Faheemullah , Asad, Ali , Yousaf, Zohaib

Journal of Endovascular Therapy | April 12, 2025 | Volume: 33 | Issue: 4 | Pages: 1642-1659

10.1177/15266028251326770 | PMID 40219609 Get It

Purpose: To systematically review the literature on the effectiveness, safety, and long-term outcomes of genicular artery embolization (GAE) for knee joint osteoarthritis (OA) associated pain. Materials and Methods: After registering the protocol with the PROSPERO database, a search was conducted from inception until July 31, 2023, in MEDLINE, Cochrane Central Register of Controlled Trials, and ScienceDirect databases to gather studies evaluating GAE’s safety and efficacy in knee OA. A total of 4979 studies were identified and evaluated against the inclusion criteria. Data on study characteristics, success parameters, and adverse events were collected and synthesized. Results: Twenty-three studies, primarily single-center prospective studies with a total of 657 patients, were included. Most studies reported a 100% technical success rates, except one study reporting a rate of 84.2%. Clinical success rates, defined variably across studies, ranged from 30% to 100%, depending on the study’s follow-up period and outcome measures. The most frequent adverse events included skin discoloration without an ulcer (15.6%, n = 98) and transient post-procedural knee pain (10.2%, n = 64). Most studies were rated as fair in terms of quality, but the lack of robust randomized controlled trials highlighted the need for further comparative studies to standardize outcome reporting. Conclusion: GAE appears to be a promising option for knee OA pain, particularly for patients unresponsive to conservative treatments or ineligible for surgery. High-quality studies are needed to confirm long-term effectiveness and standardize outcome measures. Clinical Impact This study highlights the safety and efficacy of genicular artery embolization as a minimally invasive treatment for knee osteoarthritis, particularly in patients who are unresponsive to conservative treatments or unsuitable for surgery. By targeting neovascularization and reducing inflammation, genicular artery embolization provides pain relief and functional improvement. Clinicians can consider genicular artery embolization as an alternative to surgery for mild-to-moderate OA, offering a lower adverse event rate and faster recovery.
The Association of Cannabis and Tobacco Use With Postoperative Complications after Ankle and Hindfoot Arthrodesis
Holle, Alejandro M. , Beckett, Nathan , Haglin, Jack M. , Kile, Todd A. , Beckett, Nathan C, Iturregui, Jose M. , Haglin, Jack M , Holle, Alejandro

Foot & Ankle Orthopaedics | April 12, 2025 | Volume: 10 | Issue: 2 | Pages: No page available

10.1177/24730114251328669 | PMID 40297400 Get It

Background: The purpose of this study was to investigate the association between cannabis use and postoperative complications following ankle and hindfoot arthrodesis. Methods: A retrospective cohort study using a large national insurance database from 2010 to 2022 was conducted. All patients who underwent ankle or hindfoot arthrodesis with at least 2 years’ follow-up were included. Patients were divided into 4 groups: cannabis-only users, tobacco-only users, cannabis and tobacco users, and nonuser controls. Groups were matched 1:4 with nonuser controls based on demographic variables and comorbidities. Also, both cannabis and tobacco users were matched 1:4 with tobacco-only users based on demographics and comorbidities. Medical complications within 90 days of surgery and surgery-specific complications within 2 years were compared between groups with multivariable logistic regressions. Results: Compared with nonuser controls, cannabis users only were not at increased risk of 90-day medical complications or 2-year surgical complications. Tobacco use alone was associated with increased risk of postoperative admission (OR 1.32, 95% CI 1.21-1.43) and emergency department (ED) utilization (OR 1.57, 95% CI 1.48-1.66) within 90 days as well as infection (OR 1.24, 95% CI 1.18-1.30), hardware removal (OR 1.12, 95% CI 1.07-1.18), nonunion (OR 1.33, 95% CI 1.27-1.40), and wound dehiscence (OR 1.38, 95% CI 1.27-1.49) within 2 years of surgery compared with nonuser controls. Compared with tobacco-only use, combined cannabis and tobacco use was associated with increased risk of ED visits within 90 days (OR 1.45, 95% CI 1.30-1.62) and nonunion within 2 years of surgery (OR 1.19, 95% CI 1.05-1.35). Conclusion: These findings suggest that although cannabis use alone was not associated with a higher risk of postoperative complications, its concurrent use with tobacco was linked to greater rates of adverse outcomes. Level of Evidence: Level III, retrospective case control study.
Acute Symptomatic Seizures During CAR T-Cell Therapy for Hematologic Malignancies
Freund, Brin , Feyissa, Anteneh M. , Betiku, O. A., Shar, Andy , Drees, Cornelia , Sherman, Wendy , Britton, Jeffrey W. , Barrios, Maria Silvana, Tatum, William O. , Freund, Brin E , Britton, Jeffrey W , Tatum, William O , Feyissa, A M , Sherman, Wendy Joyce , Drees, Cornelia , Qin, Hong , Barrios, Maria Silvana, ReFaey, Karim

Neurology | April 11, 2025 | Volume: 104 | Issue: 9 | Pages: No page available

10.1212/wnl.0000000000213535 | PMID 40215424 Get It

Association of Body Mass Index in Late Life, and Change from Midlife to Late Life, With Incident Dementia in the ARIC Study Participants
Cannon, Ethan , Windham, B. Gwen , Griswold, Michael , Palta, Priya , Knopman, David S. , Sedaghat, Sanaz , Lutsey, Pamela L. , Knopman, David S. , Griswold, Michael , Cannon, Ethan J , Lutsey, Pamela L

Neurology | April 11, 2025 | Volume: 104 | Issue: 9 | Pages: No page available

10.1212/wnl.0000000000213534 | PMID 40215425 Get It

Endocrine Therapy Omission in Estrogen Receptor–Low (1%-10%) Early-Stage Breast Cancer
Choong, Grace M. , Hoskin, Tanya L. , Boughey, Judy C. , Ingle, James N. , Goetz, Matthew P. , Boughey, JC , Ingle, J , Goetz, Matthew P , Hoskin, Tanya , Choong, Grace M

Journal of Clinical Oncology | April 11, 2025 | Volume: 43 | Issue: 16 | Pages: 1875-1885

10.1200/jco-24-02263 | PMID 40215443 Get It

PURPOSE Adjuvant endocrine therapy (ET) improves overall survival (OS) in estrogen receptor (ER)–positive early-stage breast cancer (BC). However, the benefit of ET for those with ER-low BC (ER 1%-10%) is unclear. METHODS Using the National Cancer Database, we studied patients with high-risk stage I to III, ER-low BC (defined as immunohistochemistry 1%-10%) who received (neo)adjuvant chemotherapy and did or did not initiate ET. OS was analyzed with ET initiation as a time-dependent covariate using Cox proportional hazards regression. RESULTS Of 10,362 patients with stage I to III ER-low BC, 7,018 received chemotherapy and met inclusion criteria. ET omission was 42% at 12 months and more common in patients with tumors that were progesterone receptor–negative, human epidermal growth factor receptor 2–negative, higher-grade (grade 2/3) and higher Ki-67 (≥20%; all P < .001) and those who received neoadjuvant chemotherapy (NAC; P < .001). With a median follow-up of 3 years, 586 deaths were observed. In a multivariable analysis, ET omission was associated with a higher risk of death (hazard ratio [HR], 1.23 [95% CI, 1.04 to 1.46]; P = .02), with a greater impact in those with higher ER levels: ER 1%-5% (HR, 1.15 [95% CI, 0.91 to 1.45]; P = .24) versus ER 6%-10% (HR, 1.42 [95% CI, 1.00 to 2.02]; P = .048). Among patients treated with NAC (n = 4,377, 62%), ET omission was associated with worse OS in those with residual disease (RD; HR, 1.26 [95% CI, 1.00 to 1.57]; P = .046) but not in those who achieved a pathologic complete response (HR, 1.06 [95% CI, 0.62 to 1.80]; P = .84). CONCLUSION In ER-low, early-stage BC, ET omission is associated with significantly worse OS, especially in patients with RD after NAC and those with higher (6%-10%) ER levels. Until prospective data are available, patients with ER-low BC should be counseled regarding the potential benefit of ET.
Implementation of Symptom Monitoring With Electronic Patient-Reported Outcomes: Perspectives and Recommendations From Community Oncology Practices (Alliance AFT-39)
Bennett, Antonia V. , Stover, Angela M. , Jönsson, Mattias , Teal, Randall, Vu, Maihan B. , Carda-Auten, Jessica , Jansen, Jennifer , Carr, Philip, Dueck, Amylou C. , Henson, Sydney, Basch, Ethan , Dueck, A. C. , Mody, Gita , Bennett, Antonia V , Stover, Angela M , Jonsson, Mattias , Jansen, Jennifer , Basch, Ethan , Mody, Gita N.

JCO Oncology Practice | April 11, 2025 | Volume: 21 | Issue: 12 | Pages: 1830-1837

10.1200/op-24-00627 | PMID 40215451 Get It

PURPOSE Monitoring with electronic patient-reported outcome (ePRO) systems can improve cancer outcomes and is increasingly recommended. Optimal implementations of ePROs in routine clinical care are not yet known. Perspectives from clinicians, clinic staff, and patients who used ePROs can provide real-world insights for optimizing the design, efficiency, and effectiveness of future implementations. METHODS Providers, clinic staff, and patients receiving treatment for metastatic cancer from community oncology practices that implemented ePROs as part of the national PRO-TECT trial (Alliance AFT-39) participated in semi-structured interviews related to ePROs. Perceptions from clinicians on perceived benefits, usefulness, acceptability, impact on quality of care, and required effort; from staff on clinical integration and effort; and from patients on ease of use, usefulness, and effort were collected. Themes, subthemes, and recommendations were identified via a standardized coding-based directed thematic analytic approach. RESULTS Ninety-eight clinic members and 67 patients participated from 25 intervention sites. Four themes were identified: (1) positive impact of ePROs on cancer care quality, communication, and relationship-building; (2) ePRO system usability; (3) challenges to ePRO integration with clinical workflow; and (4) recommendations for improving ePRO systems and implementation. Subthemes related to the impact of ePROs on cancer care included enhanced communication with care team, increased awareness of symptoms, and increased ability to self-manage symptoms. Actionable recommendations for future initiatives were to engage and train clinicians, staff, and organizational support for ePRO-related activities; tailor content of ePRO surveys to be clinically actionable; integrate ePRO alert notifications and reports with existing information systems; and optimize integration of ePROs with existing clinic workflow processes. CONCLUSION Experiences of care team members and patients were positive, with actionable recommendations identified to guide future ePRO implementations.